Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Jubilant Pharmova arm gets tentative USFDA approval for Pantoprazole Oral Suspension
Jubilant Pharmova subsidiary Jubilant Generics gets USFDA tentative nod for Pantoprazole Sodium Oral Suspension, final approval after patent expiry in Dec 2026, shares down over 10% in 6 months
Jubilant Pharmova arm gets tentative nod for Pantoprazole oral suspension
Jubilant Pharmova announced that its subsidiary, Jubilant Generics has received a tentative approval from the USFDA US Food and Drug Administration (USFDA) for Pantoprazole Sodium delayed release oral suspension, 40 mg per packet.
Stock Alert: Infosys, Vedanta, LIC, Embassy Developments, Jubilant Pharmova
Vedanta incorporated a wholly owned subsidiary, Vedanta Property Platforms (VPPL) in Mumbai, Maharashtra, to undertake real estate business and ancillary activities.
Jubilant Pharmova arm sees tax adjustment cut to ₹42 crore from ₹108 crore
Shares of Jubilant Pharmova Ltd ended at ₹973.10, down by ₹0.15, or 0.015%, on the BSE.
Jubilant Pharmova's Spokane facility gets USFDA inspection with 8 observations
Jubilant Pharmova announced completion of USFDA inspection at its contract manufacturing facility operated by Jubilant HollisterStier LLC in Spokane, Washington, USA, conducted on 17 June 2026.
USFDA inspects Jubilant HollisterStier LLC's contract manufacturing unit located at Spokane
Jubilant Pharmova announced that United States Food and Drug Administration (USFDA) has concluded an inspection of Jubilant HollisterStier LLC (JHS)'s contract manufacturing facility located in Spokane, WA. U.S.A on 17 June 2026.
Stocks to Watch today: RIL, Infosys, Wipro, HCL Tech, HDFC Bank, Acme Solar
Stocks to Watch today, June 19, 2026: Bharat Forge, Tata Motors, Jubilant Pharmova, Amber Enterprises and Mahindra Lifespace Developers are among the top stocks to remain in focus today
Jubilant Pharmova Q4 profit declines on margin pressure; revenue rises 19%
Jubilant Pharmova reported 19% revenue growth in Q4FY26, but weaker margins dragged profit lower. Shares turned volatile after earnings, while the company also announced a final dividend of ₹5 per share.
Q4 Results LIVE Updates: Max Health shares decline 7%, Honasa Consumer up 7%; Hindalco report today
Q4 Results Live Update: Another busy earnings week ends with three Nifty names - Sun Pharma, Eicher Motors and Hindalco reporting their results today, along with broader market names like Torrent Pharma, Fortis Healthcare, DAM Capital, Colgate-Palmolive, IRCON International, Jubilant Pharmova, Minda Corp, and many others. LG, LIC, GAIL, ITC, will also be reacting to their results reported on Thursday.
Paras Defence and Space Technologies Ltd leads losers in 'A' group
KEI Industries Ltd, Jubilant Pharmova Ltd, Poly Medicure Ltd and Shree Renuka Sugars Ltd are among the other losers in the BSE's 'A' group today, 10 March 2026.
Stocks to Watch Today: Kotak Bank, Torrent Power, Persistent, Aurobindo Pharma, Dr Reddys Labs, KEC International, Turtlemint, Transrail, Airtel in focus on 29 June
Stocks to Watch, 29 Jun: Stocks like Kotak Mahindra Bank, Torrent Power, Persistent Systems, Aurobindo Pharma, Indoco Remedies, BEML, Lupin, Dr Reddys Laboratories, Jubilant Pharmova, Zydus Lifesciences, Hexaware Technologies, KEC International, Bharti Airtel, and Vodafone Idea will be in focus on June 29.